305820-28-4 Usage
Uses
Used in Pharmaceutical Industry:
H-DL-DELTA-HYDROXY-DL-LYS(BOC)-OH is used as a key intermediate in the synthesis of pharmaceutical compounds, particularly those related to collagen and its modifications. Its unique structure allows for the creation of novel therapeutic agents with potential applications in various medical conditions.
Used in Research and Development:
In the field of research and development, H-DL-DELTA-HYDROXY-DL-LYS(BOC)-OH is utilized for the synthesis and characterization of collagen model peptides, specifically those containing the δ-phosphohydroxylysine residue. This helps scientists better understand the structure and function of collagen, which is crucial for the development of new treatments for collagen-related diseases.
Used in Cosmetics Industry:
H-DL-DELTA-HYDROXY-DL-LYS(BOC)-OH may also find applications in the cosmetics industry, where it can be used as an ingredient in the development of skincare products targeting collagen synthesis and skin health. Its role in promoting collagen production could potentially contribute to anti-aging and skin rejuvenation effects.
Check Digit Verification of cas no
The CAS Registry Mumber 305820-28-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,0,5,8,2 and 0 respectively; the second part has 2 digits, 2 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 305820-28:
(8*3)+(7*0)+(6*5)+(5*8)+(4*2)+(3*0)+(2*2)+(1*8)=114
114 % 10 = 4
So 305820-28-4 is a valid CAS Registry Number.
305820-28-4Relevant articles and documents
Traceless and site-specific ubiquitination of recombinant proteins
Virdee, Satpal,Kapadnis, Prashant B.,Elliott, Thomas,Lang, Kathrin,Madrzak, Julia,Nguyen, Duy P.,Riechmann, Lutz,Chin, Jason W.
, p. 10708 - 10711 (2011)
Protein ubiquitination is a post-translational modification that regulates almost all aspects of eukaryotic biology. Here we discover the first routes for the efficient site-specific incorporation of δ-thiol-l-lysine (7) and δ-hydroxy-l-lysine (8) into re